Discontinuation of antiplatelet therapy
β
Daniel J. Brotman; Mihir Bakhru; Wael Saber; Ashish Aneja; Deepak L. Bhatt; Kath
π
Article
π
2007
π
John Wiley and Sons
π
English
β 86 KB
## Abstract ## BACKGROUND Drugβeluting coronary stents (DESs) pose a challenge in the perioperative period. Sirolimus and paclitaxel may inhibit reendothelialization of the traumatized vessel, making it vulnerable to plateletβmediated thrombosis. Given the anecdotal evidence and case series sugges